Table 4.
All scores | Pre-pandemic period | Pandemic period | P |
---|---|---|---|
TNSS | 5.6 ± 2.4 (1–10) | 4.3 ± 3.1 (0–10) | 0.001 |
Nasal obstruction | 1.6 ± 0.7 (0–3) | 1.1 ± 0.9 (0–3) | < 0.001 |
Nasal discharge | 1.3 ± 0.8 (0–3) | 1 ± 0.9 (0–3) | 0.006 |
Nasal itching | 1.3 ± 0.7 (0–2) | 0.9 ± 0.9 (0–3) | 0.001 |
Sneezing | 1.4 ± 0.8 (0–3) | 1.3 ± 0.9 (0–3) | 0.117 |
TOSS | 2 ± 2.8 (0–9) | 1.7 ± 2.4 (0–9) | 0.111 |
Redness | 0.7 ± 1 (0–3) | 0.6 ± 0.8 (0–3) | 0.061 |
Itching | 0.7 ± 1 (0–3) | 0.6 ± 0.8 (0–3) | 0.022 |
Tearing | 0.6 ± 0.9 (0–3) | 0.6 ± 0.8 (0–3) | 0.827 |
TSS | 7.6 ± 4.2 (2–17) | 6 ± 4.7 (0–18) | 0.005 |
TNSS: Total Nasal Symptom Score; TOSS: Total Ocular Symptom Score; TSS: Total Symptom Score.